4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000129
Chief Executive Officer sold 15,100 shares at an average $42.67 ($644,327)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2025-10-13 | Sale 10b5-1 | −13,548 | $42.63 | $577,544 | 832,857 | D |
| Congleton Jon Chief Executive Officer | 2025-10-13 | Sale 10b5-1 | −1,552 | $43.03 | $66,782 | 831,305 | D |
| Open-market sales · 15,100 sh · avg $42.67 · $644,327 | |||||||
Loading xslF345X05/wk-form4_1760569470.xml…